NYSE: HQL - Tekla Life Sciences Investors

六个月盈利: -16.6%
股息率: +12.58%
部门: Financials

促销时间表 Tekla Life Sciences Investors


关于公司 Tekla Life Sciences Investors

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies.

更多详情
It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

IPO date 1992-05-04
ISIN US87911K1007
Industry Capital Markets
Sector Financials
Валюта usd
Валюта отчета usd
Див.доход ао 17.34
Дивиденд ао 2.33
Сайт https://www.teklacap.com/hql.html
Цена ао 12.98
每日价格变化: -0.1541% (12.98)
每周价格变化: -1.97% (13.22)
每月价格变化: -6.09% (13.8)
3个月内价格变化: -6.36% (13.84)
六个月内的价格变化: -16.6% (15.54)
每年价格变化: -3.93% (13.49)
3年内价格变化: -18.59% (15.92)
5年内价格变化: -27.27% (17.82)
年初以来价格变化: -1.44% (13.15)

低估

姓名 意义 年级
P/S 4.88 3
P/BV 0.9204 9
P/E 4.96 10
EV/EBITDA 14.85 7
全部的: 8.63

效率

姓名 意义 年级
ROA, % 19.76 6
ROE, % 19.8 6
全部的: 5.17

股息

姓名 意义 年级
Div yield, % 12.58 10
DSI 0.8571 8.57
全部的: 7.58

责任

姓名 意义 年级
Debt/EBITDA 0 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -30.15 0
盈利能力 Ebitda, % -131.71 0
盈利能力 EPS, % -41.09 0
全部的: 0

ETF分享, %本年盈利能力, %股息, %
Saba Closed End Funds ETF 2.8917 17.31 2.29022
Amplify High Income ETF 2.263 6.94 2.77149
First Trust Income Opportunities ETF 0.4681 18.3 2.48805
1.8714.182.52



导师 职称 支付 出生年份
Dr. Daniel R. Omstead M.S, Ph.D. Principal Executive Officer, President and Trustee N/A 1953 (72 年)
Mr. Peter Branner Chief Investment Officer N/A 1964 (61 年)

地址: United States, Boston. MA, 100 Federal Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.teklacap.com/hql.html